These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3439678)

  • 1. [Decrease of microalbuminuria caused by antihypertensive treatment in 10 diabetics with incipient diabetic nephropathy].
    Grimaldi A; Bosquet F; Coutarel P; Digy JP; Bordas M; Carayon A
    Ann Med Interne (Paris); 1987; 138(7):556-7. PubMed ID: 3439678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H; Klose S; Lobmann R; Zehnder D
    MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.
    Weidmann P; Schneider M; Böhlen L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():39-45. PubMed ID: 8643207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indication of vitamin E on microalbuminuria in patients with incipient diabetic nephropathy.
    Yokoyama M; Torita M; Yoshizawa M; Usuda R
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):611-2. PubMed ID: 11694862
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
    Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
    Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early screening for nephropathy initiative.
    Monsaert RP
    Del Med J; 2006 Apr; 78(4):153-4. PubMed ID: 16719144
    [No Abstract]   [Full Text] [Related]  

  • 10. Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
    de Zeeuw D
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):11S-15S; quiz A2-4. PubMed ID: 15539105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy, and the effect of antihypertensive treatment.
    Parving HH; Andersen AR; Smidt U; Friisberg B; Bonnevie-Nielsen V; Svendsen PA
    Acta Endocrinol Suppl (Copenh); 1981; 242():39-40. PubMed ID: 6940399
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregnancy in women with diabetic nephropathy--a clear indication for antihypertensive treatment].
    Girndt J
    Zentralbl Gynakol; 1994; 116(6):362-4. PubMed ID: 8048293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of losartan on albuminuria, peripheral and autonomic neuropathy in normotensive microalbuminuric type 2 diabetics.
    Kubba S; Agarwal SK; Prakash A; Puri V; Babbar R; Anuradha S
    Neurol India; 2003 Sep; 51(3):355-8. PubMed ID: 14652437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus.
    Nishikawa T; Omura M; Iizuka T; Saito I; Yoshida S
    Arzneimittelforschung; 1996 Sep; 46(9):875-8. PubMed ID: 8876935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy].
    Shestakova MV; Chugunova LA; Vorontsov AV; Dedov II
    Ter Arkh; 1997; 69(6):34-7. PubMed ID: 9297270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ACE inhibitors and early diabetic nephropathy].
    Bangstad HJ; Hartmann A; Berg TJ; Hanssen KF
    Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3039-41. PubMed ID: 7570536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic nephropathy--methods of preventing and inhibiting progression].
    Klinger M
    Przegl Lek; 1995; 52(4):138-40. PubMed ID: 7638360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.